The aim is to improve the participant’s knowledge of diagnosis/treatment, and to improve practices in order to be better prepared for the future. Course topics will range from current best practices for diagnosis to advanced technologies for improving management in a context of multi-drug resistant pathogens becoming more and more widespread or in light of new concepts and new approaches (e.g. biofilm or anti-infective lock therapy in catheterassociated BSI). The course will focus on strategies to shorten time-to-result and to improve BSI detection (e.g. novel molecular tools), BSI diagnosis and management-based advanced technologies and how these advanced methodologies will be implemented in the next 5 years. The course will also cover a cost effectiveness approach of novel tool implementation. The lectures will be delivered by a range of European experts, and several lectures will include a joint perspective of microbiologists/infectious disease specialists designed to improve
patient management.
20 – 60 microbiologists and infectious disease specialists who want to get updated knowledge of the theoretical and practical aspects of current and advanced diagnosis and management of bloodstream infection (BSI).
Yehuda Carmeli, Tel Aviv, Israel
Brigitte Lamy, Nice, France
Frederic Laurent, Lyon, France
ESCMID Fungal Infection Study Group - EFISG
ESCMID Study Group for Biofilms - ESGB
ESCMID Study Group for Bloodstream Infections and Sepsis - ESGBIS
ESCMID Study Group for Epidemiological Markers - ESGEM
ESCMID Study Group for Genomic and Molecular Diagnostics - ESGMD
ESCMID Study Group for Staphylococci and Staphylococcal Diseases - ESGS
University of Nice-Sofia Antipolis/Université Côte d’Azur





The event was granted 18 European CME credits (ECMEC) by the European Accreditation Council for Continuing Medical Education (EACCME).

Speakers


Maiken Cavling Arendrup, Copenhagen, Denmark
Patrick Baqué, Nice, France
Thomas Bjarnsholt, Copenhagen, Denmark
Emilio Bouza Santiago, Madrid, Spain
Yehuda Carmeli, Tel Aviv, Israel
Jordi Carratala, Barcelona, Spain
Sylvie Dargere, NA, France
Francesco Giuseppe De Rosa, Torino, Italy
Noa Eliakim-Raz, Petach-Tikvah, Israel
Pierre-Edouard Fournier, Marseille, France
Jean-Marc Ghigo, Paris, France
Dubourg Grégory, Marseille, France, France
Hajo Grundmann, Freiburg, Germany
Iñaki Gutiérrez-Ibarluzea, Vitoria-Gasteiz, Spain
Elena Jordana Lluch, Nottingham, United Kingdom
Achim Kaasch, Düsseldorf, Germany
Brigitte Lamy, Nice, France
Frederic Laurent, Lyon, France
David Lebeaux, Paris, France
Gregoire Mercier, Montpellier, France
Malgorzata Mikulska, Genoa, Italy
David Morquin, Montpellier, France
John W. A. Rossen, Groningen, Netherlands
Raymond Ruimy, Nice, France
ETIENNE RUPPE, GENEVA, Switzerland
Martin Sundqvist, Örebro, Sweden
Pierre Tattevin, Rennes, France
Estee Torok, Cambridge, United Kingdom
Francois Vandenesch, Lyon, France
Andreas F. Widmer, Basel, Switzerland

Contact Person (Scientific Programme)

Brigitte Lamy
CHU Nice
Bacteriology
151, Route de Saint Antoine de Ginestière
06200 Nice
France
+33 6 13 05 65 03
+33 4 92 03 59 52
brigitte_lamy@yahoo.fr

Administrative Secretariat

CHU Nice Bacteriology
CHU Nice
Bacteriology
151, Route Saint Antoine de Ginestière
06200 Nice
France
+33 4 92 03 62 14
+33 4 92 03 59 52
educational.course.nice@gmail.com

Accommodation Details

New York Hotel
44, Avenue Marechal Foch
06000 Nice
France
http://www.bestwestern.fr/
+33 4 93 85 14 31

Venue Info

Event Map
Venue Details
Hôpital L’Archet 2
151, Route de Saint Antoine de Ginestière , 06200 Nice
France
Phone: +33 6 13 05 65 03
Fax: +33 4 92 03 59 52
Email: brigitte_lamy@yahoo.fr

Tuesday, 28 March 2017

12:00 - 13:45
Welcome and registration
13:45 - 14:00
Introduction
Speaker(s): Patrick Baqué
Speaker(s): Brigitte Lamy
14:00 - 15:50
The diagnosis of BSI: the classical approach I
Chairperson(s): Maiken Cavling Arendrup
14:00 - 14:40
Blood culture: from theoretical aspects to best practice guidelines
Speaker(s): Brigitte Lamy
14:40 - 15:20
Candidaemia and invasive candidiasis: BC and beyond
Speaker(s): Maiken Cavling Arendrup
15:20 - 15:50
Contaminants in BC: importance, implications, interpretation and prevention
Speaker(s): Sylvie Dargere
15:50 - 16:15
Coffee break
16:15 - 18:30
Strategies to improve the quality of BC-based diagnosis
Chairperson(s): Yehuda Carmeli
16:15 - 16:55
Shorten delays to get results: a hospital-level organizational approach. The experience of Montpellier’s hospital
Speaker(s): David Morquin
16:55 - 17:20
Blood culture pre-analytic quality management in the era of norm 15189 accreditation
Speaker(s): Brigitte Lamy
17:20 - 17:55
Strategies to improve quality of management based on BC order
Speaker(s): Emilio Bouza Santiago

Wednesday, 29 March 2017

09:00 - 11:00
Advanced technologies: how to perform better and faster I
Chairperson(s): Brigitte Lamy
09:00 - 10:00
Genotypic methods from positive BC bottles: a critical analysis of the current and next generation rapid methods
Speaker(s): John W. A. Rossen
10:00 - 11:00
Phenotypic methods from positive BC bottles: where we are and where we are going – a critical analysis of the current and next generation rapid methods
Speaker(s): Dubourg Grégory
Speaker(s): Raymond Ruimy
11:00 - 11:30
Coffee break
11:30 - 12:30
Advanced technologies: how to perform better and faster II
Chairperson(s): John W. A. Rossen
11:30 - 12:00
Detect BSI quickly and identify pathogens with culture-free methods: pipe dream, reality or future?
Speaker(s): Elena Jordana Lluch
12:00 - 12:30
Rapid methods: what is the impact on patient management?
Speaker(s): Martin Sundqvist
12:30 - 14:00
Lunch
14:00 - 18:00
Advanced technologies: what to expect for BSI diagnostic within 5 years
Chairperson(s): Frederic Laurent
14:00 - 15:00
How to implement? An ID perspective vs a microbiologist perspective.
Speaker(s): John W. A. Rossen
15:00 - 15:30
New and costly... not for any patient! The medico-economic perspective I: stratify the likelihood of bacteraemia to improve the cost/benefit of advanced technologies? Strengths and weaknesses of models for predicting bacteraemia
Speaker(s): Noa Eliakim-Raz
15:30 - 16:30
New and costly... not for any patient! The medico-economic perspective II: how to finance? A health economist perspective
Speaker(s): Iñaki Gutiérrez-Ibarluzea
Speaker(s): Gregoire Mercier
16:30 - 17:00
Coffee break
17:00 - 18:00
Staphyloccus capitis in neonatal sepsis in NICUs: from the local epidemiology to a worldwide endemicity... from ward to pathophysiology
Speaker(s): Frederic Laurent
18:00 - 20:30
End of day – social activity
20:30 - 22:30
Dinner

Thursday, 30 March 2017

08:30 - 10:15
What to expect from NGS for bloodstream infections I
Chairperson(s): Francois Vandenesch
08:45 - 09:30
Is NGS for BSI diagnosis and resistance detection realistic? Myths and real-life applications in a next future
Speaker(s): ETIENNE RUPPE
09:30 - 10:15
NGS for understanding global epidemics
Speaker(s): Hajo Grundmann
10:15 - 10:45
Coffee break
10:45 - 12:00
What to expect from NGS for bloodstream infections II
Chairperson(s): Hajo Grundmann
10:45 - 11:15
NGS for understanding local epidemics
Speaker(s): Estee Torok
11:15 - 12:00
Potential predictors of infective endocarditis in the course of S. aureus bacteremia
Speaker(s): Francois Vandenesch
12:00 - 13:30
Lunch
13:30 - 15:05
Central line-associated BSI I: new concepts, new approaches, and news from biofilms (and more)
Chairperson(s): Jean-Marc Ghigo
13:30 - 14:15
CLABSI pathogen detection methods and consequences for management
Speaker(s): Andreas F. Widmer
14:15 - 14:40
Where is differential time to positivity most relevant for catheter-related infection – if at all?
Speaker(s): Achim Kaasch
14:40 - 15:05
Focus: will biofilm concepts change the diagnostic approach of CLABSI pathogen detection?
Speaker(s): Thomas Bjarnsholt
15:05 - 15:30
Coffee break
15:30 - 17:45
Central line-associated BSI and news from biofilms II: impact of new concepts on treatment management
Chairperson(s): Thomas Bjarnsholt
15:30 - 16:15
Clinical data regarding the anti-infective lock technique: biofilm strikes back
Speaker(s): David Lebeaux
16:15 - 17:00
What is the place for biofilm antimicrobial susceptibility testing for choosing anti-infective lock therapy and antimicrobial therapy?
Speaker(s): Thomas Bjarnsholt
17:00 - 17:45
From biofilm models to treatment: the anti-infective lock technique: a new hope
Speaker(s): Jean-Marc Ghigo
17:45 - 18:15
End of day

Friday, 31 March 2017

08:30 - 09:30
BSI in special patient groups – bridging lab and clinical expertise I
Chairperson(s): Malgorzata Mikulska
08:30 - 09:00
Strategy to improve BSI diagnosis in haematology cancer patients: which methods and what timing for what performances?
Speaker(s): Malgorzata Mikulska
09:00 - 09:30
News on BSI in transplant patients
Speaker(s): Jordi Carratala
09:30 - 09:55
Coffee break
09:55 - 11:45
BSI in special patient groups – bridging lab and clinical expertise II
Chairperson(s): Francesco Giuseppe De Rosa
09:55 - 10:25
Early dynamics of microbial load, persistent bacteraemia and prognosis in patients with endocarditis
Speaker(s): Achim Kaasch
10:25 - 10:50
Positive follow-up on blood cultures: Why? When? For which patient? Consequence on patient management
Speaker(s): Francesco Giuseppe De Rosa
10:50 - 11:20
Pathogen viability versus DNA detection in excised heart valves – consequences for therapy duration/de-escalation
Speaker(s): Pierre Tattevin
11:20 - 11:45
Is there a consensus about pathogen detection targets and methods in culture-negative endocarditis?
Speaker(s): Pierre-Edouard Fournier
11:45 - 11:55
Course evaluation
11:55 - 12:10
Questions, feedback, certificates
12:10 - 13:00
Closing lunch
13:00 - 13:30
End of meeting and departure

28-Feb-2017
750
950
The registration fee includes 3 nights of accommodation, lunches, coffee breaks, teaching materials and social activities (includes one dinner). Travel is not included.
27-Jan-2017
10-Feb-2017